We asked if a higher percentage of PD-L1-expressing macrophages in pancreatic TME would impact overall survival in patients with a diagnosis of pancreatic ductal adenocarcinoma (PDAC). This evidence concerns the gene CD274 and pancreatic ductal adenocarcinoma.